Role of Hyaluronic Acid Treatment in the Prevention Of Keloid Scarring

Overview

Journal J Am Coll Clin Wound Spec

Date 2014 Jun 18

PMID 24936445

Citations 6

Authors

Andrea Hoffmann

Jessica Lynn Hoing

Mackenzie Newman

Richard Simman

Affiliations

Soon will be listed here.

Abstract

Background: Keloids are benign dermal scars characterized by enhanced growth factor signaling, hyperproliferation activity and reduced extracellular matrix (ECM) deposition of hyaluronic acid. Our hypothesis is that high molecular weight HA can be used to replenish HA deposition in keloids thereby normalizing the keloid fibroblast phenotype.

Methods: One normal (NF1) fibroblast culture and five keloid (KF1, KF2, KF3, KF4, KF5) fibroblast cultures were analyzed for changes in hyperproliferation, growth factor production and extracellular matrix deposition following 72 hour treatment with or without 10 μg/ml HA.

Results: Proliferation activity decreased significantly in KF3 following HA treatment. Pro-collagen I expression in KF2 was decreased following HA treatment in association with changes in fiber arrangement to more parallel collagen bundles. In addition, HA demonstrated a downregulation on TGF-b1 growth factor expression in KF3 and KF4 and a decrease in active TGF-b1 release in KF2 and KF5 using ELISA.

Conclusion: Our data demonstrates that HA has the potential to normalize keloid fibroblast characteristic features such as hyperproliferation, growth factor production and ECM deposition depending on the specific genotype of the keloid fibroblast cell line. This study suggests that high molecular weight HA can be used to replenish HA deposition in keloid fibroblasts thereby decreasing fibrosis and ultimately decreasing keloid manifestation.

Citing Articles

Future Directions About Keloid Scars Based on Pathogenesis and Therapies.

Zhang G, Liu Z, Li Z, Xu Y Clin Cosmet Investig Dermatol. 2024; 17:2391-2408.

PMID: 39474263 PMC: 11520916. DOI: 10.2147/CCID.S470650.

Pharmacotherapy for Keloids and Hypertrophic Scars.

Murakami T, Shigeki S Int J Mol Sci. 2024; 25(9).

PMID: 38731893 PMC: 11083137. DOI: 10.3390/ijms25094674.

Preparation of tanshinone II self-soluble microneedles and its inhibition on proliferation of human skin fibroblasts.

Zhan Y, Xu X, Luo X, Liu R, Lin Y, Zhao P Chin Herb Med. 2023; 15(2):251-262.

PMID: 37265770 PMC: 10230632. DOI: 10.1016/j.chmed.2022.10.002.

Hyaluronan Functions in Wound Repair That Are Captured to Fuel Breast Cancer Progression.

Tolg C, Messam B, McCarthy J, Nelson A, Turley E Biomolecules. 2021; 11(11).

PMID: 34827550 PMC: 8615562. DOI: 10.3390/biom11111551.

Efficacy of hyaluronic acid film on perianal wound healing in a rat model.

Cho J, Lee M, Oh H, Kim H, Kweon D, Kang S Ann Surg Treat Res. 2021; 101(4):206-213.

PMID: 34692592 PMC: 8506023. DOI: 10.4174/astr.2021.101.4.206.

References

Uitto J, Perejda A, Abergel R, Chu M, Ramirez F . Altered steady-state ratio of type I/III procollagen mRNAs correlates with selectively increased type I procollagen biosynthesis in cultured keloid fibroblasts. Proc Natl Acad Sci U S A. 1985; 82(17):5935-9. PMC: 390668. DOI: 10.1073/pnas.82.17.5935. View

Tuan T, Nichter L . The molecular basis of keloid and hypertrophic scar formation. Mol Med Today. 1998; 4(1):19-24. DOI: 10.1016/S1357-4310(97)80541-2. View

Messadi D, Le A, Berg S, Jewett A, Wen Z, Kelly P . Expression of apoptosis-associated genes by human dermal scar fibroblasts. Wound Repair Regen. 2000; 7(6):511-7. DOI: 10.1046/j.1524-475x.1999.00511.x. View

Leach J, Bivens K, Patrick Jr C, Schmidt C . Photocrosslinked hyaluronic acid hydrogels: natural, biodegradable tissue engineering scaffolds. Biotechnol Bioeng. 2003; 82(5):578-89. DOI: 10.1002/bit.10605. View

Park S, Kim J, Suh H . Evaluation of antibiotic-loaded collagen-hyaluronic acid matrix as a skin substitute. Biomaterials. 2004; 25(17):3689-98. DOI: 10.1016/j.biomaterials.2003.10.072. View

Duncan M, Hasan A, Berman B . Oncostatin M stimulates collagen and glycosaminoglycan production by cultured normal dermal fibroblasts: insensitivity of sclerodermal and keloidal fibroblasts. J Invest Dermatol. 1995; 104(1):128-33. DOI: 10.1111/1523-1747.ep12613623. View

Kennedy C, Diegelmann R, Haynes J, Yager D . Proinflammatory cytokines differentially regulate hyaluronan synthase isoforms in fetal and adult fibroblasts. J Pediatr Surg. 2000; 35(6):874-9. DOI: 10.1053/jpsu.2000.6869. View

Cho Y, Lee J, Lee J, Lee J, Yoon T, Kuroyanagi Y . Hyaluronic acid and silver sulfadiazine-impregnated polyurethane foams for wound dressing application. J Mater Sci Mater Med. 2004; 13(9):861-5. DOI: 10.1023/a:1016500429225. View

Wolfram D, Tzankov A, Pulzl P, Piza-Katzer H . Hypertrophic scars and keloids--a review of their pathophysiology, risk factors, and therapeutic management. Dermatol Surg. 2009; 35(2):171-81. DOI: 10.1111/j.1524-4725.2008.34406.x. View

10.

Boraldi F, Croce M, Quaglino D, Sammarco R, Carnevali E, Tiozzo R . Cell-matrix interactions of in vitro human skin fibroblasts upon addition of hyaluronan. Tissue Cell. 2003; 35(1):37-45. DOI: 10.1016/s0040-8166(02)00101-5. View

11.

Croce M, Boraldi F, Quaglino D, Tiozzo R, Pasquali-Ronchetti I . Hyaluronan uptake by adult human skin fibroblasts in vitro. Eur J Histochem. 2003; 47(1):63-73. DOI: 10.4081/808. View

12.

Anderson I . The properties of hyaluronan and its role in wound healing. Prof Nurse. 2002; 17(4):232-5. View

13.

Abergel R, Pizzurro D, Meeker C, Lask G, Matsuoka L, Minor R . Biochemical composition of the connective tissue in keloids and analysis of collagen metabolism in keloid fibroblast cultures. J Invest Dermatol. 1985; 84(5):384-90. DOI: 10.1111/1523-1747.ep12265471. View

14.

Taylor K, Trowbridge J, Rudisill J, Termeer C, Simon J, Gallo R . Hyaluronan fragments stimulate endothelial recognition of injury through TLR4. J Biol Chem. 2004; 279(17):17079-84. DOI: 10.1074/jbc.M310859200. View

15.

Bettinger D, Mast B, Gore D . Hyaluronic acid impedes reepithelialization of skin graft donor sites. J Burn Care Rehabil. 1996; 17(4):302-4. DOI: 10.1097/00004630-199607000-00004. View

16.

Belmont A, Kendall F, Nicolini C . Coupling of nuclear morphometry to cell geometry and growth in human fibroblasts. Cell Biophys. 1980; 2(2):165-75. DOI: 10.1007/BF02795842. View

17.

DePalma R, Krummel T, Durham 3rd L, Michna B, Thomas B, Nelson J . Characterization and quantitation of wound matrix in the fetal rabbit. Matrix. 1989; 9(3):224-31. DOI: 10.1016/s0934-8832(89)80054-x. View

18.

Dang C, Beanes S, Soo C, Ting K, Benhaim P, Hedrick M . Decreased expression of fibroblast and keratinocyte growth factor isoforms and receptors during scarless repair. Plast Reconstr Surg. 2003; 111(6):1969-79. DOI: 10.1097/01.PRS.0000054837.47432.E7. View

19.

Chipev C, Simman R, Hatch G, Katz A, Siegel D, Simon M . Myofibroblast phenotype and apoptosis in keloid and palmar fibroblasts in vitro. Cell Death Differ. 2000; 7(2):166-76. DOI: 10.1038/sj.cdd.4400605. View

20.

Brown J, Ollier W, Arscott G, Ke X, Lamb J, Day P . Genetic susceptibility to keloid scarring: SMAD gene SNP frequencies in Afro-Caribbeans. Exp Dermatol. 2008; 17(7):610-3. DOI: 10.1111/j.1600-0625.2007.00654.x. View